These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6763376)

  • 1. [Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation].
    Malikova EV; Safonova LS; Zueva LP; Znakova GM
    Tr Inst Im Pastera; 1982; 57():122-3. PubMed ID: 6763376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. II. The results of a study of the reactogenic properties of the vaccine].
    Karpukhin GI; Popov IV; Malikova EV
    Tr Inst Im Pastera; 1976; 47():156-9. PubMed ID: 802567
    [No Abstract]   [Full Text] [Related]  

  • 3. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunogenic and reactogenic properties of commercial series of inactivated chromatographic influenza vaccine].
    Peĭsel' SG; Nifontova AI; Zhebrun AB; Karpovich NM; Slatin EA
    Tr Inst Im Pastera; 1979; 52():38-42. PubMed ID: 550545
    [No Abstract]   [Full Text] [Related]  

  • 5. [Obtaining a lyophilized preparation of inactivated influenza vaccine].
    Goriunova VV; Bichurina MA; Gerasimov VA
    Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. I. Laboratory evaluation data].
    Karpukhin GI; Popov IV; Malikova EV
    Tr Inst Im Pastera; 1976; 47():154-6. PubMed ID: 1052580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibility of preparing inactivated influenza vaccine by a combination of gel chromatography and ultrafiltration].
    Fridman AL; Ermolaev AI; Bichurina MA; Polianskaia NIu; Zheleznova NV
    Tr Inst Im Pastera; 1979; 52():103-7. PubMed ID: 550531
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain].
    Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu
    Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasal influenza vaccine enters Phase I clinical trial.
    Expert Rev Vaccines; 2007 Jun; 6(3):305. PubMed ID: 17542745
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 16. Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review.
    Boyce TG; Poland GA
    Biomed Pharmacother; 2000 May; 54(4):210-8. PubMed ID: 10872719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory control of the purity of chromatographic influenza vaccine].
    Bichurina MA; Goriunova VV; Zhebrun AB; Chubarova NI
    Tr Inst Im Pastera; 1979; 52():121-8. PubMed ID: 121646
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivated chromatographic influenza vaccine.
    Peradze T; Friedman E; Bitchurina M
    Med Biol; 1981 Feb; 59(1):41-6. PubMed ID: 7266085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of influenza vaccine in children.
    Goldstein LG
    Ann Pharmacother; 2003 Nov; 37(11):1712-5. PubMed ID: 14565808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.